CRISPRBIOTIC
Live / Registered — Registered (as of 23 Jun 2020)
What this means for you
Registered since 23 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88511801
- Registration number
- 6083472
- Mark type
- Stylized text
- Filed
- 12 Jul 2019
- Published for opposition
- 07 Apr 2020
- Registered
- 23 Jun 2020
- Attorney of record
- Mark H. Tidman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; clinical trials; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical research
- Class 044 — Medical, beauty and agricultural services: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling
Owner
- SNIPR Biome ApS, Copenhagen, DK
- SNIPR Biome ApS, Copenhagen, DK
- SNIPR Biome ApS, Copenhagen, DK
Prosecution history
- 23 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 07 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Apr 2020 — PUBLISHED FOR OPPOSITION
- 18 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Mar 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 02 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jan 2020 — ASSIGNED TO LIE
- 28 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Sept 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Sept 2019 — NON-FINAL ACTION E-MAILED
- 28 Sept 2019 — NON-FINAL ACTION WRITTEN
- 28 Sept 2019 — ASSIGNED TO EXAMINER